NO952748L - Polypeptid som spesifikt inhiberer Cathepsin L. - Google Patents
Polypeptid som spesifikt inhiberer Cathepsin L.Info
- Publication number
- NO952748L NO952748L NO952748A NO952748A NO952748L NO 952748 L NO952748 L NO 952748L NO 952748 A NO952748 A NO 952748A NO 952748 A NO952748 A NO 952748A NO 952748 L NO952748 L NO 952748L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- cathepsin
- osteoporosis
- specifically inhibits
- well
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 102000004172 Cathepsin L Human genes 0.000 title abstract 3
- 108090000624 Cathepsin L Proteins 0.000 title abstract 3
- 208000001132 Osteoporosis Diseases 0.000 abstract 3
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 206010039984 Senile osteoporosis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28327093 | 1993-11-12 | ||
| JP31353393A JP3276753B2 (ja) | 1993-11-12 | 1993-12-14 | カテプシンl特異的阻害ポリペプチド |
| PCT/JP1994/001878 WO1995013302A1 (en) | 1993-11-12 | 1994-11-08 | Cathepsin-l-specific inhibitor polypeptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952748D0 NO952748D0 (no) | 1995-07-11 |
| NO952748L true NO952748L (no) | 1995-07-11 |
Family
ID=26554960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952748A NO952748L (no) | 1993-11-12 | 1995-07-11 | Polypeptid som spesifikt inhiberer Cathepsin L. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5698519A (de) |
| EP (1) | EP0679659B1 (de) |
| JP (1) | JP3276753B2 (de) |
| KR (1) | KR950704358A (de) |
| AT (1) | ATE178909T1 (de) |
| AU (1) | AU671783B2 (de) |
| CA (1) | CA2151059A1 (de) |
| DE (1) | DE69417872T2 (de) |
| HU (1) | HU214343B (de) |
| NO (1) | NO952748L (de) |
| WO (1) | WO1995013302A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2481489A1 (en) * | 2002-11-29 | 2004-06-17 | Morinaga Milk Industry Co., Ltd. | Cysteine protease inhibitor |
| WO2004084830A2 (en) * | 2003-03-21 | 2004-10-07 | Buck Institute | Method for treating alzheimer’s dementia |
| US20070203073A1 (en) * | 2005-06-22 | 2007-08-30 | Diamond Scott L | SARS and Ebola inhibitors and use thereof, and methods for their discovery |
| WO2008112917A2 (en) * | 2007-03-13 | 2008-09-18 | Uti Limited Partnership | Peptidyl fluoromethylketones as inhibitors of viral replication |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3938971A1 (de) * | 1989-11-24 | 1991-05-29 | Biotechnolog Forschung Gmbh | Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat |
-
1993
- 1993-12-14 JP JP31353393A patent/JP3276753B2/ja not_active Expired - Fee Related
-
1994
- 1994-11-08 CA CA002151059A patent/CA2151059A1/en not_active Abandoned
- 1994-11-08 KR KR1019950702358A patent/KR950704358A/ko not_active Abandoned
- 1994-11-08 AT AT94931695T patent/ATE178909T1/de not_active IP Right Cessation
- 1994-11-08 WO PCT/JP1994/001878 patent/WO1995013302A1/ja not_active Ceased
- 1994-11-08 AU AU80674/94A patent/AU671783B2/en not_active Ceased
- 1994-11-08 DE DE69417872T patent/DE69417872T2/de not_active Expired - Fee Related
- 1994-11-08 HU HU9501580A patent/HU214343B/hu not_active IP Right Cessation
- 1994-11-08 EP EP94931695A patent/EP0679659B1/de not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/478,520 patent/US5698519A/en not_active Expired - Fee Related
- 1995-07-11 NO NO952748A patent/NO952748L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE178909T1 (de) | 1999-04-15 |
| WO1995013302A1 (en) | 1995-05-18 |
| DE69417872D1 (en) | 1999-05-20 |
| HU214343B (hu) | 1998-03-02 |
| AU8067494A (en) | 1995-05-29 |
| JP3276753B2 (ja) | 2002-04-22 |
| NO952748D0 (no) | 1995-07-11 |
| JPH07179496A (ja) | 1995-07-18 |
| EP0679659A4 (de) | 1996-05-22 |
| HUT73415A (en) | 1996-07-29 |
| EP0679659B1 (de) | 1999-04-14 |
| KR950704358A (ko) | 1995-11-20 |
| HU9501580D0 (en) | 1995-09-28 |
| DE69417872T2 (de) | 1999-08-12 |
| EP0679659A1 (de) | 1995-11-02 |
| US5698519A (en) | 1997-12-16 |
| CA2151059A1 (en) | 1995-05-18 |
| AU671783B2 (en) | 1996-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20092860L (no) | 2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse | |
| NO20006718L (no) | Proteaseinhibitorer | |
| TW261608B (de) | ||
| DE69634678D1 (de) | Verbesserung oder heilung von durch ischämischen krankheiten hervorgerufenen symtomen und dafür verwendbare phenylpiperidinverbingungen | |
| NZ248377A (en) | Use of interleukin-1 beta protease and interleukin-1 beta protease inhibitors | |
| AP9200410A0 (en) | Retroviral protease inhibitors. | |
| ATE245977T1 (de) | Therapeutische substituierte guanidine | |
| ATE147981T1 (de) | Verabreichung von lamotrigin zur behandlung von neuro-aids | |
| ATE262895T1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| BR9809306A (pt) | Inibidores de protease | |
| ITFI920078A0 (it) | Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umana. | |
| EP0985671A4 (de) | PYRIDOCARBAZOL DERIVATE DIE EINEN cGMP-PDE INHIBILIERENDEN EFFEKT HABEN | |
| ATE245447T1 (de) | Inhibitor von gehirnödemen | |
| ATE181336T1 (de) | Die knochenresorption hemmende verbindungen und zusammensetzungen | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| AU671783B2 (en) | Cathepsin-L-specific inhibitor polypeptide | |
| ES2097368T3 (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres. | |
| EP0355409A3 (de) | Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS | |
| ES2119746T3 (es) | Nuevo peptido fisiologicamente activo y agente regulador del metabolismo del calcio que comprende dicho peptido como ingrediente activo. | |
| DK0826373T3 (da) | Forebyggende middel mod postoperativ astigmatisme | |
| UY25369A1 (es) | Procedimiento para preparar inhibidores de proteasa | |
| GEP19991605B (en) | Inhibitor, Its Obtaining and Use |